Quantitative Systematic Strategies LLC Dexcom Inc Transaction History

Quantitative Systematic Strategies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$84.79 - $104.74 $188,657 - $233,046	-2,225 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $95,706 - $128,221	1,227 Added 122.95%	2,225 $823,000
Q3 2020 Nov 09, 2020	SELL	$95.51 - $112.95 $58,929 - $69,690	-617 Reduced 38.2%	998 $411,000
Q2 2020 Aug 04, 2020	BUY	$62.68 - $105.34 $48,702 - $81,849	777 Added 92.72%	1,615 $655,000
Q1 2020 May 06, 2020	SELL	$47.79 - $75.63 $386,143 - $611,090	-8,080 Reduced 90.6%	838 $226,000
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $208,294 - $325,865	5,688 Added 176.1%	8,918 $1.95 Million
Q3 2019 Nov 07, 2019	SELL	$35.53 - $43.8 $54,929 - $67,714	-1,546 Reduced 32.37%	3,230 $482,000
Q2 2019 Jul 25, 2019	BUY	$27.84 - $38.92 $132,963 - $185,881	4,776 New	4,776 $716,000
Q4 2018 Feb 12, 2019	SELL	$26.99 - $37.37 $56,975 - $78,888	-2,111 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $49,291 - $77,515	2,111 New	2,111 $302,000

1,112

364M

4.1M

3.65M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.